{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-099404","form_type":"8-K","ticker":"DMRA","cik":"0001800315","company_name":"Damora Therapeutics, Inc.","filed_at":"2026-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.216030+00:00","generated_at":"2026-05-15T16:51:12.833824+00:00","sec_items":["2.02","5.03","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Galecto rebrands as Damora Therapeutics (DMRA); $535M cash; DMR-001 IND mid-2026","bullets":["Name changed from Galecto to Damora Therapeutics; trades on Nasdaq as DMRA from March 10, 2026.","Preliminary cash and cash equivalents ~$535M as of Feb 28, 2026, including ~$316M from Feb 2026 public offering.","DMR-001 (anti-mutCALR antibody) IND/CTA on track for mid-2026; proof-of-concept data expected mid-2027.","DMR-002 IND/CTA planned for H2 2026; DMR-003 IND/CTA in 2027.","Acquisition of privately held Damora closed Nov 2025 with ~$285M private investment."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-099404","json":"https://secwatch.observer/filing/0001193125-26-099404.json","markdown":"https://secwatch.observer/filing/0001193125-26-099404.md","text":"https://secwatch.observer/filing/0001193125-26-099404.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800315/000119312526099404/0001193125-26-099404-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800315/000119312526099404/dmra-20260306.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T16:51:12.833824+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d4b1a745a394b7881437a3a2603933cd880178c1","claim":"Damora Therapeutics, Inc.: Amended certificate of incorporation to change company name from Galecto, Inc. to Damora Therapeutics, Inc (effective 2026-03-10).","evidence_excerpt":"On March 6, 2026, the Company filed with the Secretary of State of the State of Delaware an amendment to its Amended and Restated Certificate of Incorporation to change the name of the Company from \"Galecto, Inc.\" to \"Damora Therapeutics, Inc.\" (the \"Name Change Amendment\"). The Name Change Amendment became effective at 12:01 a.m. Eastern Time on March 10, 2026.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1800315/000119312526099404/0001193125-26-099404-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001062993-26-002388","ticker":"WAMFF","company_name":"Alaska Silver Corp.","filed_at":"2026-05-07T23:59:59+00:00","headline":"Alaska Silver simplifies capital structure, eliminates dual-class shares","event_type":"other_material","sec_items":["3.03","5.03","7.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-26-002388","json":"https://secwatch.observer/filing/0001062993-26-002388.json","markdown":"https://secwatch.observer/filing/0001062993-26-002388.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1893899/000106299326002388/0001062993-26-002388-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1893899/000106299326002388/form8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 6, 2026, the Company filed with the Secretary of State of the State of Delaware an amendment to its Amended and Restated Certificate of Incorporation to change the name of the Company from \"Galecto, Inc.\" to \"Damora Therapeutics, Inc.\" (the \"Name Change Amendment\"). The Name Change Amendment became effective at 12:01 a.m. Eastern Time on March 10, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1800315/000119312526099404/0001193125-26-099404-index.htm","comparable_excerpt":"On May 6, 2026, the Board of Directors of Alaska Silver Corp. (the \"Company\"), approved an amendment (the \"Amendment\") to the Company's Articles of the Company to eliminate its dual-class share structure by (i) eliminating its proportionate voting share class and (ii) reidentifying its subordinate voting share class as the class of \"Common Shares,\" no par value, of which the Company shall be authorized to issue an unlimited number of Common Shares.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1893899/000106299326002388/0001062993-26-002388-index.htm"}},{"accession":"0001104659-26-057200","ticker":"CUK","company_name":"CARNIVAL PLC","filed_at":"2026-05-07T23:59:59+00:00","headline":"Carnival completes DLC unification and redomiciliation to Bermuda; Carnival plc now a subsidiary","event_type":"other_material","sec_items":["1.02","2.01","3.01","3.02","3.03","5.01","5.03","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-057200","json":"https://secwatch.observer/filing/0001104659-26-057200.json","markdown":"https://secwatch.observer/filing/0001104659-26-057200.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1125259/000110465926057200/0001104659-26-057200-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/815097/000110465926057200/tm2613680d1_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 6, 2026, the Company filed with the Secretary of State of the State of Delaware an amendment to its Amended and Restated Certificate of Incorporation to change the name of the Company from \"Galecto, Inc.\" to \"Damora Therapeutics, Inc.\" (the \"Name Change Amendment\"). The Name Change Amendment became effective at 12:01 a.m. Eastern Time on March 10, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1800315/000119312526099404/0001193125-26-099404-index.htm","comparable_excerpt":"In addition, Carnival Corporation also migrated its jurisdiction of incorporation from the Republic of Panama to Bermuda and changed its name to \"Carnival Corporation Ltd.\" (the \"Redomiciliation\" and, together with the DLC Unification, the \"DLC Unification and Redomiciliation Transactions\").","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1125259/000110465926057200/0001104659-26-057200-index.htm"}},{"accession":"0001104659-26-055632","ticker":"ENZN","company_name":"Viskase Holdings, Inc.","filed_at":"2026-05-05T23:59:59+00:00","headline":"Viskase Holdings adopts Section 382 Rights Plan to protect NOL assets; threshold at 4.9%","event_type":"other_material","sec_items":["1.01","3.03","5.03","7.01","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-055632","json":"https://secwatch.observer/filing/0001104659-26-055632.json","markdown":"https://secwatch.observer/filing/0001104659-26-055632.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/727510/000110465926055632/0001104659-26-055632-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/727510/000110465926055632/tm2613382d1_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 6, 2026, the Company filed with the Secretary of State of the State of Delaware an amendment to its Amended and Restated Certificate of Incorporation to change the name of the Company from \"Galecto, Inc.\" to \"Damora Therapeutics, Inc.\" (the \"Name Change Amendment\"). The Name Change Amendment became effective at 12:01 a.m. Eastern Time on March 10, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1800315/000119312526099404/0001193125-26-099404-index.htm","comparable_excerpt":"In connection with the adoption of the Section 382 Rights Agreement, the Board approved a Certificate of Designation of Series A-2 Junior Participating Preferred Stock of Viskase Holdings, Inc. (the “Certificate of Designation”). The Certificate of Designation was filed with the Secretary of the State of Delaware on May 5, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/727510/000110465926055632/0001104659-26-055632-index.htm"}},{"accession":"0001193125-26-204723","ticker":"MTNE","company_name":"CH4 Natural Solutions Corp","filed_at":"2026-05-05T23:59:59+00:00","headline":"CH4 Natural Solutions Corporation prices $200M IPO; begins trading on NYSE","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","7.01","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-204723","json":"https://secwatch.observer/filing/0001193125-26-204723.json","markdown":"https://secwatch.observer/filing/0001193125-26-204723.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2044817/000119312526204723/0001193125-26-204723-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2044817/000119312526204723/d211764d8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 6, 2026, the Company filed with the Secretary of State of the State of Delaware an amendment to its Amended and Restated Certificate of Incorporation to change the name of the Company from \"Galecto, Inc.\" to \"Damora Therapeutics, Inc.\" (the \"Name Change Amendment\"). The Name Change Amendment became effective at 12:01 a.m. Eastern Time on March 10, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1800315/000119312526099404/0001193125-26-099404-index.htm","comparable_excerpt":"Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The Company’s Amended and Restated Memorandum and Articles of Association (as so amended, the “ Memorandum and Articles ”) were approved on April 30, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2044817/000119312526204723/0001193125-26-204723-index.htm"}},{"accession":"0001493152-26-021119","ticker":"INHD","company_name":"INNO HOLDINGS INC.","filed_at":"2026-05-04T23:59:59+00:00","headline":"Inno Holdings to effect 1-for-20 reverse stock split on May 4, 2026 for Nasdaq compliance","event_type":"other_material","sec_items":["5.03","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-021119","json":"https://secwatch.observer/filing/0001493152-26-021119.json","markdown":"https://secwatch.observer/filing/0001493152-26-021119.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1961847/000149315226021119/0001493152-26-021119-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1961847/000149315226021119/form8-k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 6, 2026, the Company filed with the Secretary of State of the State of Delaware an amendment to its Amended and Restated Certificate of Incorporation to change the name of the Company from \"Galecto, Inc.\" to \"Damora Therapeutics, Inc.\" (the \"Name Change Amendment\"). The Name Change Amendment became effective at 12:01 a.m. Eastern Time on March 10, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1800315/000119312526099404/0001193125-26-099404-index.htm","comparable_excerpt":"On April 30, 2026, Inno Holdings Inc., a Texas holding company (the “Company”) filed a Certificate of Amendment to the Certificate of Formations of the Company with the Secretary of State of the State of Texas (the “Certificate of Amendment”) that provides for a 1-for-20 reverse stock split (the “Reverse Stock Split”) of its issued and outstanding shares of common stock, with no par value (the “Common Stock”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1961847/000149315226021119/0001493152-26-021119-index.htm"}},{"accession":"0001104659-26-053557","ticker":"CWEN","company_name":"Clearway Energy, Inc.","filed_at":"2026-05-01T23:59:59+00:00","headline":"Clearway Energy eliminates Class A stock; converts all shares to reduced-vote Class C","event_type":"other_material","sec_items":["1.01","3.03","5.03","5.07","7.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-053557","json":"https://secwatch.observer/filing/0001104659-26-053557.json","markdown":"https://secwatch.observer/filing/0001104659-26-053557.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1567683/000110465926053557/0001104659-26-053557-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1567683/000110465926053557/tm2613249d1_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 6, 2026, the Company filed with the Secretary of State of the State of Delaware an amendment to its Amended and Restated Certificate of Incorporation to change the name of the Company from \"Galecto, Inc.\" to \"Damora Therapeutics, Inc.\" (the \"Name Change Amendment\"). The Name Change Amendment became effective at 12:01 a.m. Eastern Time on March 10, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1800315/000119312526099404/0001193125-26-099404-index.htm","comparable_excerpt":"Following the Class A Conversion, on May 1, 2026, the Company filed with the Delaware Secretary of State a certificate of retirement pursuant to Section 243 of the DGCL (the “Certificate of Retirement”) to retire all shares of Class A common stock converted in the Class A Conversion, which also had the effect of amending the Amended Charter to (i) reduce the total number of authorized shares of Class A common stock from 34,613,853 to zero, (ii) reduce the total number of authorized shares of capital stock of the Company from 2,544,613,853 to 2,510,000,000 and (iii) eliminate from the Amended Charter all references to the Class A common stock (collectively, the “Class A Retirement”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1567683/000110465926053557/0001104659-26-053557-index.htm"}},{"accession":"0001493152-26-019787","ticker":"QXL","company_name":"Viewbix Inc.","filed_at":"2026-04-30T23:59:59+00:00","headline":"Viewbix renamed Quantum X Labs Inc.; Nasdaq ticker changes to QXL","event_type":"other_material","sec_items":["5.03","7.01","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-019787","json":"https://secwatch.observer/filing/0001493152-26-019787.json","markdown":"https://secwatch.observer/filing/0001493152-26-019787.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/797542/000149315226019787/0001493152-26-019787-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/797542/000149315226019787/form8-k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 6, 2026, the Company filed with the Secretary of State of the State of Delaware an amendment to its Amended and Restated Certificate of Incorporation to change the name of the Company from \"Galecto, Inc.\" to \"Damora Therapeutics, Inc.\" (the \"Name Change Amendment\"). The Name Change Amendment became effective at 12:01 a.m. Eastern Time on March 10, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1800315/000119312526099404/0001193125-26-099404-index.htm","comparable_excerpt":"effective April 30, 2026, the Company amended and restated its Amended and Restated Bylaws (the \"Bylaws\") to reflect the Name Change (the \"A&R Bylaws\"). The A&R Bylaws contain no other changes.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/797542/000149315226019787/0001493152-26-019787-index.htm"}},{"accession":"0001185185-26-002273","ticker":"DGAC","company_name":"DISCIPLINED GROWTH ACQUISITION Corp","filed_at":"2026-06-01T20:15:34+00:00","headline":"Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-26-002273","json":"https://secwatch.observer/filing/0001185185-26-002273.json","markdown":"https://secwatch.observer/filing/0001185185-26-002273.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/0001185185-26-002273-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/dgac8k052926.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 6, 2026, the Company filed with the Secretary of State of the State of Delaware an amendment to its Amended and Restated Certificate of Incorporation to change the name of the Company from \"Galecto, Inc.\" to \"Damora Therapeutics, Inc.\" (the \"Name Change Amendment\"). The Name Change Amendment became effective at 12:01 a.m. Eastern Time on March 10, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1800315/000119312526099404/0001193125-26-099404-index.htm","comparable_excerpt":"On May 26, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) with the Cayman Islands Registrar of Companies, which was effective on May 26, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/0001185185-26-002273-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}